GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: These results have further enriched our understanding of the activity of Gata2-L359V in blocking the differentiation of BCR/ABL-expressing CML stem/progenitor cells, thus helping us comprehend the stepwise pathogenesis in this unique disease model.